Name: Interest Coverage

Definition: Interest coverage tells you how easily the company can pay interest on its debt using operating profits. It’s like asking: “Can the company comfortably make its loan payments, or is it barely scraping by?” The higher the ratio, the safer. A very low ratio means debt payments may strain the business, especially if profits drop.

Interpretation:
• In '2021', DTIL's interest coverage was -230.83, indicating the firm's ability to meet its interest obligations. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2021' stood at -1.38.
• In '2022', DTIL's interest coverage was -64.62, indicating the firm's ability to meet its interest obligations. The increase since '2021' reflects strengthening financial performance. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2022' stood at -2.54. Industry average declined by 1.16 from previous year.
• In '2023', DTIL's interest coverage was -18.07, indicating the firm's ability to meet its interest obligations. The increase since '2022' reflects strengthening financial performance. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2023' stood at -2.47. Industry average increased by 0.07 compared to previous year.
• In '2024', DTIL's interest coverage was 5.02, indicating the firm's ability to meet its interest obligations. The increase since '2023' reflects strengthening financial performance. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2024' stood at -0.85. Industry average increased by 1.63 compared to previous year.
Overall, DTIL's interest coverage has been volatile but showed an upward trend over the past 4 years.

Formula: Interest Coverage = EBIT / Interest Expense

Good Range: Minimum 3-5 desirable; below 1 is risky.